Skip to main content
Earnings Labs
NE

Neuphoria Therapeutics Inc. (NEUP)

NASDAQ·Healthcare·Medical - Pharmaceuticals

$4.30

+0.23%

Mkt Cap $8.54M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$7.00

Range $7.00$7.00

Implied Upside

+62.8%

Consensus $7.00 vs current $4.30